A detailed history of Fullcircle Wealth LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Fullcircle Wealth LLC holds 11,250 shares of SMMT stock, worth $235,012. This represents 0.11% of its overall portfolio holdings.

Number of Shares
11,250
Previous 12,209 7.85%
Holding current value
$235,012
Previous $122 Million 105.34%
% of portfolio
0.11%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$6.89 - $31.93 $6,607 - $30,620
-959 Reduced 7.85%
11,250 $250 Million
Q2 2024

Jul 25, 2024

BUY
$2.39 - $10.92 $29,179 - $133,322
12,209 New
12,209 $122 Million

Others Institutions Holding SMMT

About Summit Therapeutics Inc.


  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $4.2B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Fullcircle Wealth LLC Portfolio

Follow Fullcircle Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fullcircle Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fullcircle Wealth LLC with notifications on news.